KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

Point-of-care ultrasound (POCUS) in acute hospitalized older ... The safety and efficacy of tolvaptan in the treatment of patients with autosomal dominant polycystic kidney disease: a systematic ...

Delray Medical Center cut the ribbon on its newest high-tech machine last week that targets brain areas to treat movement disorders such as essential tremor and tremor-dominant Parkinson's disease.

The device delivers ultrasound energy to the patient’s pancreas and generates localized heat of up to 100 degrees Celsius that destroys cancer cells in the organ. Other types of ultrasound waves ...

But after a couple of years of work, xMEMS has arrived at the next generation — ultrasound through a solid-state speaker. This tiny, 1mm-thin speaker is called Cypress, and after listening to it ...

Assessing the safety, tolerability, pharmacokinetics, and pharmacodynamics of the medication in adult ADPKD patients, the research is a double-blind, placebo-controlled experiment. For three ...

(RTTNews) - Regulus Therapeutics Inc. (RGLS) Wednesday announced positive clinical as well as regulatory updates from its autosomal dominant polycystic kidney disease (ADPKD) program. Topline ...